Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.
Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 8:45 AM ET on Thursday, June 24th with the first live webcast at 9:00 AM ET.
REGISTER NOW AT: https://bit.ly/2P9cmZK
It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.
Agenda and presenting companies:
| Presentation Time (ET) | Presenting Company | Ticker(s) |
| 9:00 AM | Cybin Inc. | (OTCQB: CLXPF | NEO: CYBN) |
| 9:30 AM | Else Nutrition Holdings Inc | (OTCQX: BABYF | TSX-V: BABY) |
| 10:00 AM | Shield Therapeutics PLC | (OTCQX: SHIEF | LSE: STX) |
| 10:30 AM | Innocan Pharma Corp. | (OTCQB: INNPF | CSE: INNO) |
| 11:00 AM | Lexaria Bioscience Corp. | (NASDAQ: LEXX, | CSE: LXX) |
| 11:30 AM | Diffusion Pharmaceuticals Inc. | (NASDAQ: DFFN) |
| 12:00 PM | Field Trip Health Ltd. | (OTCQX: FTRPF | TSX: FTRP) |
| 12:30 PM | InMed Pharmaceuticals Inc. | (NASDAQ: INM) |
| 1:00 PM | Assure Holdings Corp | (OTCQB: ARHH | TSX-V: IOM) |
| 1:30 PM | VolitionRx Limited | (NYSE AMERICAN: VNRX) |
| 2:00 PM | Avricore Health Inc. | (OTCQB: AVCRF | TSX-V: AVCR) |
| 2:30 PM | Starpharma Holdings Ltd. | (OTCQX: SPHRY | ASX: SPL) |
| 3:00 PM | Neonmind Biosciences Inc. | (OTCQB: NMDBF | CSE: NEON) |
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
| Last Trade: | US$1.06 |
| Daily Change: | 0.02 1.92 |
| Daily Volume: | 166,756 |
| Market Cap: | US$18.600M |
April 28, 2025 December 19, 2024 December 17, 2024 December 09, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
